Implications for IV posaconazole dosing in the era of obesity

BACKGROUND: The prevalence of obesity has shown a dramatic increase over recent decades. Obesity is associated with underdosing of antimicrobial drugs for prophylaxis and treatment. Posaconazole is a broad-spectrum triazole antifungal drug licensed for prophylaxis and treatment of invasive fungal in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasmann, Roeland E, Smit, Cornelis, van Donselaar, Marieke H, van Dongen, Eric P A, Wiezer, René M J, Verweij, Paul E, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069473/
https://www.ncbi.nlm.nih.gov/pubmed/31971567
http://dx.doi.org/10.1093/jac/dkz546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069473/
https://www.ncbi.nlm.nih.gov/pubmed/31971567
http://dx.doi.org/10.1093/jac/dkz546

Ejemplares similares